Ritaline en es it fr

Ritaline Brand names, Ritaline Analogs

Ritaline Brand Names Mixture

  • No information avaliable

Ritaline Chemical_Formula


Ritaline RX_link


Ritaline fda sheet

Ritaline FDA

Ritaline msds (material safety sheet)

Ritaline MSDS

Ritaline Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Ritaline Molecular Weight

233.306 g/mol

Ritaline Melting Point


Ritaline H2O Solubility


Ritaline State


Ritaline LogP


Ritaline Dosage Forms

Tablets; Tablets (sustained release)

Ritaline Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Ritaline Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Ritaline Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Ritaline side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Ritaline Patient Information

Ritaline Organisms Affected

Humans and other mammals